TARLOV CYST DISEASE FOUNDATION (EIN 205724680) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

CATHY GRAY CARLOMAGNO

Phone

6157424200

Tax Period

2024-01-01 to 2024-12-31

TARLOV CYST DISEASE FOUNDATION, founded in 2006, is a micro nonprofit in the Medical Research sector that reported $48K in total revenue in fiscal year 2024. Revenue surged 128% from the prior year, signaling strong growth momentum. Expenses of $147K exceeded revenue, resulting in a 205% operating deficit.

Mission

The Tarlov Cyst Disease Foundation is a volunteer-based, 501(c)(3) non-profit foundation dedicated to the research, improved diagnosis and development of successful treatments and outcomes for symptomatic Tarlov cysts. The Foundation is incorporated exclusively for scientific, educational, and charitable purposes that will seek to improve the level of understanding, diagnosis and treatment of Tarlov cysts.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,497

Program Service Revenue $0

Investment Income $45,722

Other Revenue $0

TOTAL REVENUE $48,219

Expense Breakdown

Grants Paid $0

Salaries & Benefits $132,000

Fundraising Expenses $0

Program Expenses $112,154

Other Expenses $15,123

TOTAL EXPENSES $147,123

Year-over-Year Comparison

	2024	2023	Change
Revenue	$48,219	$21,139	+1.3%
Expenses	$147,123	$37,221	+3.0%
Net Income	$-98,904	$-16,082	+5.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$132,000

Total Directors

$132,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RETA HONEY HIERS RNC	Past Exec Dir	20.00	Officer Director	$132,000	$0	$132,000
SANDY A ROOF	Secretary	1.00	Officer Director	$0	$0	$0
IRIS KACHUCK	Vice President	1.00	Officer Director	$0	$0	$0
CATHY GRAY CARLOMAGNO	Treasurer	5.00	Officer Director	$0	$0	$0
MICHELLE LEAR	Director	1.00	Director	$0	$0	$0
GAIL NELSON	President	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$48,219	$147,123	$2,916,528	$-98,904

TARLOV CYST DISEASE FOUNDATION